Skip to main content

Table 9 Details of intermolecular interactions at the binding site of Temozolomide drug with proteins C-MET, C-ROS1 and ALK

From: Docking and dynamic simulation study of Crizotinib and Temozolomide drug with Glioblastoma and NSCLC target to identify better efficacy of the drug

Protein

Name

Name of the site and pose number

Type of interaction

Category

The interacting amino acid in the binding site with Temozolomide drug

Distance

2WGJ

DIRECT(P4)

Conventional hydrogen bond

Hydrogen bond

5394:H16:A: MET1160:O

2.24481

  

Carbon hydrogen bond

Hydrogen bond

5394:H17A: PRO1158:O

2.45839

  

Pi-Pi stacked

Hydrophobic

:5394—A: TYR1159

4.93012

  

Pi-alkyl

Hydrophobic

:5394—A:VAL1092

:5394—A:MET1211

:5394—A:MET1211

:5394—A:MET1160

:5394—A:ALA1108

:5394—A:ALA1108

4.83973

3.91876

3.77984

5.1382

4.89055

4.93458

  

Alkyl

Hydrophobic

A:ALA1226:5394:C13

:5394:C13:A:LEU1157

4.39785

4.69299

3ZBF

PDB(P4)

Conventional hydrogen bond

Hydrogen bond

5394:H16:A:MET2029:O

2.42253

  

Carbon hydrogen bond

Hydrogen bond

5394:H17-A:GLU2027:O

2.32972

  

Alkyl

Hydrophobic

5394:C13—A:LEU2010

5394:C13—A:LEU2026

5394:C13—A:LEU2086

5.45684

4.55133

5.3763

  

Pi-alkyl

Hydrophobic

5394—A:VAL1959

5394—A:ALA1978

5394—A:ALA1978

5394—A:LEU2028

5394—A:LEU2086

5394—A:LEU2086

5.24465

4.34067

3.69966

5.1594

4.34929

4.68103

2XP2

RC(S1, P2)

Conventional hydrogen bond

Hydrogen bond

A:ARG1275:HH12-5394:O2

A:ARG1275:HH22-5394:O2

A:ARG1275:HH22-5394:N6

5394:H15-A:GLU1167:OE2

5394:H16—A:ASP1160:O

2.24837

2.41096

2.23388

2.94087

2.61508

  

Carbon hydrogen bond

Hydrogen bond

A:ASP1160:HA—5394:N5

5394:H17- A:ASP1160:OD1

5394:H18- A:ASP1276:OD2

2.73974

2.25332

2.33541

  

Pi-anion

Electrostatic

A:ASP1163:OD2—5394

3.68967